In multiple myeloma, bispecific CAR-T cells targeting BCMA and CS1 exhibited accelerated clearance of tumor cells in several mouse models when combined with a PD-1-blocking antibody [62]. The gene discussed is TNFRSF17; the disease is plasma cell myeloma.